GlobalData’s patient-based forecast predicts that MSD’s enlicitide will achieve blockbuster status in 2031.

Enlicitide, an Investigational Oral PCSK9 Inhibitor, Demonstrated Significantly Greater LDL-C Reductions Compared to Oral Non ...

Join the 2026 Confluence Trash Bash in St. Louis on April 11 to protect the Mississippi and Missouri River watersheds through ...

Tēnā koutou katoa, thank you for inviting me to join you at the Immigration Law Symposium. It’s a privilege to be here today and speak about the work we’ve delivered in the immigration portfolio over ...

A curled toenail often begins as a small cosmetic change that seems easy to ignore. Then the nail thickens, the shoe rubs ...

Picture this: you’re aboard the USS Nimitz, a floating city stretching over three football fields in length, home to more ...

MSD/Merck & Co's headquarters in Rahway, New Jersey. MSD has said it plans to separate its cancer and non-cancer pharma operations as it prepares for the looming loss of patent protection for $31 ...

MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

Positive Data from Phase 2 CADENCE Trial Provides Definitive Proof-of-Concept for Merck’s WINREVAIR in Adults With CpcPH-HFpEF ...

Supplemental Instruction is an academic assistance program providing regularly scheduled out-of-class, peer-led study sessions for challenging courses. The free sessions, open to all students in ...

Technology provides instant accessibility to information, which is why its presence in the classroom is so vital. Smart phones, computers, and tablets are already an omnipresent element of everyday ...

LSIPR sister title launches vetted list celebrating leading in-house counsel who demonstrate exceptional ability in managing ...